What laboratory tests should be ordered for a postpartum patient to assess anemia, electrolyte status, thyroid function, glucose control, infection, blood type, and other relevant conditions?

Postpartum Laboratory Testing

Routine universal laboratory testing in all postpartum patients is not recommended; instead, adopt a selective, risk-based approach focusing on hemoglobin assessment for anemia and targeted thyroid screening in high-risk women.

Hemoglobin/Anemia Assessment

Selective hemoglobin testing based on clinical risk factors is the preferred strategy over routine universal testing. The 2025 Enhanced Recovery After Surgery (ERAS) guidelines for cesarean delivery support selective rather than routine postoperative laboratory evaluation 1.

When to Check Hemoglobin:

• High-risk patients requiring testing:
  • Preoperative hemoglobin <11 g/dL
  • Blood loss >500 mL at delivery
  • Multiple uterotonic agents required
  • Symptomatic patients (fatigue, dizziness, tachycardia, dyspnea)
  • Cesarean delivery with complications

A 2026 predictive model demonstrated that using just two variables (preoperative hemoglobin and number of uterotonic agents) can reduce postoperative testing by 65% while maintaining 90% sensitivity for detecting severe anemia 2. This validates the selective approach.

Timing and Thresholds:

• If testing is indicated: Check at 48 hours postpartum or at the postpartum visit (1 week)
• Anemia definitions:
  • <11 g/dL at 1 week postpartum
  • <12 g/dL at 8 weeks postpartum 3, 4

Management Based on Results:

• Hemoglobin <7 g/dL or symptomatic: Consider transfusion 1
• Hemoglobin 7-11 g/dL: Oral iron supplementation (100-200 mg elemental iron daily) 4
• Severe anemia with poor response: Consider IV iron 800-1500 mg 4

Common pitfall: Avoid routine hemoglobin testing in low-risk women (normal preoperative hemoglobin, minimal blood loss, asymptomatic). This represents unnecessary resource utilization without improving outcomes.

Thyroid Function Testing

Universal thyroid screening is NOT recommended for all postpartum women 5. However, targeted screening is essential for high-risk groups.

High-Risk Groups Requiring TSH Testing:

• Women with positive TPO antibodies (anti-thyroid peroxidase): Check TSH at 6-12 weeks postpartum 5
• Type 1 diabetes: Screen at 3 and 6 months postpartum 5
• History of postpartum thyroiditis: Screen at 3 and 6 months postpartum 5
• Graves' disease in remission: Screen at 3-6 months for recurrence 5
• Symptomatic patients: Those with thyrotoxic symptoms (palpitations, weight loss, tremor) or hypothyroid symptoms (fatigue, cold intolerance, depression) 6

What to Order:

• Initial test: TSH alone is sufficient for screening 5
• If TSH abnormal: Add free T4 and TPO antibodies
• If hyperthyroidism suspected: Add TSH receptor antibodies (TRAb) 5

The prevalence of postpartum thyroid dysfunction is 4.4%, with 62% of TPO-positive women developing thyroid dysfunction 6. This justifies targeted rather than universal screening.

Glucose Testing (For Women with Gestational Diabetes)

All women with gestational diabetes require postpartum glucose screening, but NOT at the immediate postpartum hospitalization.

Recommended Approach:

• Timing: At the 6-week postpartum visit (not during hospitalization)
• Test options:
  • Preferred in-office approach: Fasting glucose + HbA1c at the postpartum visit (identifies 93% of dysglycemia) 7
  • Traditional approach: 75g oral glucose tolerance test (OGTT) at outside laboratory

The in-office testing model (fasting glucose + HbA1c) doubles testing compliance compared to requiring OGTT at outside laboratories (100% vs 53%) 7. This makes it the pragmatic choice despite OGTT being the traditional gold standard.

Critical point: Over 70% of women with GDM will develop diabetes, but only 30% complete recommended testing when OGTT is required 7. Simplifying the testing process dramatically improves follow-through.

Blood Type and Antibody Screen

Only order if:

• Not documented during prenatal care
• Significant bleeding occurred requiring potential transfusion
• Rh-negative status needs confirmation for RhoGAM administration

This should have been completed prenatally in routine care.

Electrolytes

Routine electrolyte testing is NOT indicated in uncomplicated postpartum patients.

Order electrolytes only if:

• Preeclampsia with magnesium sulfate administration
• Significant hemorrhage with large-volume resuscitation
• Renal dysfunction
• Symptomatic hyponatremia or other electrolyte disturbance

While anemia correlates with electrolyte abnormalities (particularly calcium, potassium, magnesium) 8, routine screening in asymptomatic postpartum women is not supported by guidelines.

Tests NOT Routinely Recommended

• Complete metabolic panel: Not indicated unless specific clinical concern
• Liver function tests: Only if preeclampsia, HELLP syndrome, or hepatic concerns
• Coagulation studies: Only if bleeding disorder suspected or anticoagulation management needed
• Infection markers (CBC with differential, CRP): Only if fever, signs of infection, or endometritis suspected

Summary Algorithm

For ALL postpartum patients:

1. Assess clinical risk factors (not routine labs)
2. Selective hemoglobin testing if preoperative anemia, significant bleeding, multiple uterotonics, or symptoms
3. No routine thyroid, glucose, or electrolyte testing during hospitalization

For HIGH-RISK subgroups:

• TPO-positive, Type 1 diabetes, prior postpartum thyroiditis: TSH at 6-12 weeks
• Gestational diabetes: Fasting glucose + HbA1c at 6-week visit
• Severe anemia (Hb <7) or symptomatic: Consider transfusion; otherwise oral iron

This selective approach reduces unnecessary testing by approximately 65% while maintaining safety and improving resource utilization 1, 2.